| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/02/2001 | EP1095935A1 6-Hydroxy-5,6-dihydrouracils as herbicides |
| 05/02/2001 | EP1095933A1 Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1095028A1 Substituted acylamino phenyl uracils |
| 05/02/2001 | EP1095027A1 Substituted phenyl uracils |
| 05/02/2001 | EP1095026A1 Pharmaceutical agents |
| 05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | CN1293674A Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/02/2001 | CN1293666A Benzenesulfonamide-derivatives and their use as medicaments |
| 05/02/2001 | CN1293665A New compounds and their use as positive AMPA receptor modulators |
| 05/02/2001 | CN1293662A Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 05/02/2001 | CN1293082A Alkylated ammonia alkyl cyclic urea surface active agent |
| 05/02/2001 | CN1065265C Photo-cross-linkable 1,2-phenylene derivatives |
| 05/01/2001 | US6225470 Heating substituted aminoalkenamides in presence of diluents to produce ar(alk)yluracil |
| 05/01/2001 | US6225329 Useful in the treatment of type i diabetes, type ii diabetes, impaired glucose tolerance, insulin autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases |
| 05/01/2001 | US6225318 4-aminoquinazolone derivatives |
| 05/01/2001 | US6225317 Reverse transcriptase inhibitor |
| 05/01/2001 | US6225315 Administering a cgmp pde inhibitor. |
| 05/01/2001 | US6225288 Implicated in modulating apoptosis; treatment of:cardiac and cerebral ischemia/reperfusion injury, spinal cord injury and organ damage during transplantation, chronic neurodegenerative diseases, immunodeficiency, diabetes, alopecia, aging |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 04/26/2001 | WO2001029010A1 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/26/2001 | WO2001029009A1 4,5-disubstituted-2-aminopyrimidines |
| 04/26/2001 | WO2001028561A1 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/26/2001 | WO2001028537A2 Bissulfonamide derivatives as enzyme inhibitors |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | CA2387593A1 Enzyme inhibitors |
| 04/26/2001 | CA2387034A1 4,5-disubstituted-2-aminopyrimidines |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/25/2001 | CN1292783A Method for preparing sulfanyl-type endothelin receptor antagonists |
| 04/25/2001 | CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists |
| 04/25/2001 | CN1292700A IgE antibody production inhibitors and autoimmune diseases inhibitors |
| 04/24/2001 | US6222037 Reacting 4,6-dimethoxypyrimidin-2-isocyante with 2-sulfonamido-pyridine compound in aprotic solvent to form potassium or sodium n-pyridylsulfonyl-n'-pyrimidinylurea compound |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222034 As serotinin receptor antagonists; for therapy of depression, central nervous system disorders |
| 04/24/2001 | US6221907 Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221872 Debrominating a pyrrole; fusing the product with an amidine; condensing the product with a nucleophile; reducing and purifying |
| 04/24/2001 | US6221871 Treating schizophrenia, depression or parkinson's disease |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/24/2001 | US6221852 Pharmaceutical compositions of 5-alkynyl-dideoxyribouracil |
| 04/24/2001 | US6221196 Wetting a support element in region of adhesion zone with liquid composition of adhesion promoter to form coating; solidifying coating; shaping and solidifying elastomeric material by vulcanization |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027103A1 Fab i inhibitors |
| 04/19/2001 | WO2001027090A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRINαvβ3 ANTAGONISM |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027087A2 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2392209A1 M-substituted benzoic acid derivatives having integrin .alpha.v.beta.3 antagonistic activity |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/18/2001 | EP1092710A1 Alkylated aminoalkyl cyclic urea surfactants |
| 04/18/2001 | EP1091960A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP1091739A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 04/18/2001 | EP1091737A2 Calcium channel blockers |
| 04/18/2001 | EP0572429B1 Sulfonyl urea derivates, method for preparing them and use thereof |
| 04/18/2001 | CN1291978A Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists |
| 04/17/2001 | US6218539 Phenyl ureas |
| 04/17/2001 | US6218538 Antagonists of n-type neuronal calcium channels useful in the treatment of cerebrovascular ischaemia and pain. |
| 04/17/2001 | US6218404 Therapy and prophylaxis of neuronal loss associated with stroke, ischemia, cns trauma, hypoglycemia and surgery, neuro-degenerative diseases including alzheimer's disease, amyotrophic lateral sclerosis, huntington's disease |
| 04/17/2001 | US6218397 For therapy of stress-related illnesses, such as stress-induced depression, anxiety, and headache; abdominal bowel syndrome; inflammatory diseases; immune suppression; alzheimer's disease; gastronintestinal diseases |
| 04/17/2001 | CA2191340C Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
| 04/17/2001 | CA2158457C Naphthalene derivatives |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025235A1 Macrocyclic quinazolinones and their use as local anesthetics |
| 04/12/2001 | WO2001025234A1 Quinazolinones and analogues and their use as local anesthetics |
| 04/12/2001 | WO2001025229A1 Amide compounds |
| 04/12/2001 | WO2001025218A1 Novel quinazoline derivatives |
| 04/12/2001 | WO2001025217A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/12/2001 | WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386163A1 Novel quinazoline derivatives |
| 04/12/2001 | CA2386157A1 Amide compounds |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1089987A1 Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers |
| 04/11/2001 | EP1089984A1 Non-yellowing para-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP0873317B1 Pyrimidin derivatives |
| 04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/10/2001 | US6215030 Catalytic reduction of acids, esters and anhydrides to alcohols |
| 04/10/2001 | CA2086974C R(+)-terazosin |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/05/2001 | WO2001023365A1 Quinazolinones |
| 04/05/2001 | WO2001023364A1 Quinazolinones |
| 04/05/2001 | WO2001023363A1 Sulfonamide derivatives |